After meeting with UnitedHealth's management, Wedbush believes that the company's low costs will enable it to gain share among younger customers. The firm thinks the company's growth can accelerate over time, while its multiple is poised to rise. Wedbush keeps a $138 price target and Outperform rating on the name.
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here